3D Reconstruction and Generative AI in Undergraduate Urology Clerkship

November 7, 2026 updated by: Ju Guo, Nanchang University

A Structured 3D Reconstruction and Generative AI Program in Undergraduate Urology Clerkship: A Baseline-Adjusted Group Comparison

This study examined whether a structured teaching program that combines three-dimensional reconstruction of kidney cases with generative artificial intelligence dialogue helps undergraduate medical students learn during their urology clerkship. One hundred and eighty students took part between September 2024 and January 2025. Students who received the combined program were compared with students who received conventional multimedia teaching. Both groups completed knowledge and clinical reasoning tests before and after teaching, and students in the combined group also completed satisfaction questionnaires. The study was registered after the teaching period had ended.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nanchang, China
        • The First Affiliated Hospital of Nanchang University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fourth-year undergraduate medical students enrolled in the urology clerkship at The First Affiliated Hospital of Nanchang University between September 2024 and January 2025
  • Attended the full 150-minute teaching session
  • Completed both the pre-teaching and post-teaching assessments

Exclusion Criteria:

  • Incomplete pre-teaching or post-teaching assessment data
  • Did not attend the full 150-minute teaching session

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combined program (3D reconstruction and generative AI)

A 150-minute structured session in which three-dimensional reconstructed renal tumor and stone cases were inspected, followed by generative artificial intelligence case dialogue with feedback and small-group discussion.

A 150-minute structured session: three-dimensional reconstructed renal tumor and stone cases were inspected, followed by generative artificial intelligence case dialogue with feedback and small-group discussion.

Active Comparator: Conventional multimedia teaching

Students received conventional multimedia teaching.

A 150-minute multimedia lecture-based session covering urological anatomy and the principles of renal tumor and renal stone diagnosis and management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urology knowledge test score
Time Frame: Baseline and immediately after the 150-minute session (September 2025 to January 2026)

Thirty multiple-choice items on urological anatomy, diagnosis and management, scored 0 to 100. Administered immediately before and after the teaching session; the primary measure is the post-intervention score adjusted for the corresponding pretest score.

Baseline and immediately after the 150-minute session (September 2025 to January 2026)
Clinical reasoning score
Time Frame: Baseline and immediately after the 150-minute session (September 2025 to January 2026)

Structured clinical reasoning assessment based on urological case vignettes, scored 0 to 100. Administered immediately before and after the teaching session; the primary measure is the post-intervention score adjusted for the corresponding pretest score.

Baseline and immediately after the 150-minute session (September 2025 to January 2026)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with the teaching program
Time Frame: Immediately after the 150-minute session

Self-reported satisfaction questionnaire scored 0 to 100, completed by students in the combined program after the session.

Immediately after the 150-minute session
Engagement with the generative AI dialogue
Time Frame: During the 150-minute session

Number of interaction turns per case dialogue and the proportion of responses judged clinically correct, extracted from the AI platform logs.

During the 150-minute session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Actual)

January 1, 2026

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

November 7, 2026

First Submitted That Met QC Criteria

November 7, 2026

First Posted (Actual)

November 13, 2026

Study Record Updates

Last Update Posted (Actual)

November 13, 2026

Last Update Submitted That Met QC Criteria

November 7, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • URO-EDU-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.